A Single Center, Single Sequence, Open-Label, Repeat-Dose Study to Investigate the Effect of GSK376501 on Hepatic Cytochrome P450 Activity in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 28 Feb 2008
At a glance
- Drugs GSK 376501 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 26 Feb 2008 New trial record.